Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 11, 2022
Total Value: $275M (95.2% shares, 4.8% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MORPHIC HLDG INC | 399,302 | $18.92M | 6.9% | $51.97 | — | COM | 61775R105 |
| — | SPRINGWORKS THERAPEUTICS INC | 298,545 | $18.5M | 6.7% | $63.44 | — | COM | 85205L107 |
| SAVA | CASSAVA SCIENCES INC | 350,000 | $15.29M | 5.6% | — | — | Put | 14817C107 |
| — | VINCERX PHARMA INC | 1,135,365 | $11.57M | 4.2% | $16.73 | — | COM NEW | 92731L106 |
| — | INARI MED INC | 125,000 | $11.41M | 4.1% | $92.39 | — | COM | 45332Y109 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 117,500 | $9.877M | 3.6% | $57.90 | +33.6% | COM | 98943L107 |
| — | ARENA PHARMACEUTICALS INC | 100,000 | $9.294M | 3.4% | $92.94 | — | COM NEW | 040047607 |
| — | CHINOOK THERAPEUTICS INC | 555,155 | $9.055M | 3.3% | $16.22 | — | COM | 16961L106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 241,119 | $8.246M | 3.0% | $31.61 | 0.0% | COM | 74366E102 |
| BBIO | BRIDGEBIO PHARMA INC | 494,046 | $8.241M | 3.0% | $59.66 | -29.1% | COM | 10806X102 |
| KURA | KURA ONCOLOGY INC | 560,000 | $7.84M | 2.8% | $29.31 | -44.7% | COM | 50127T109 |
| — | TRAVERE THERAPEUTICS INC | 7,000,000 | $7.731M | 2.8% | $0.94 | — | NOTE 2.500% 9/1 | 761299AB2 |
| MRNA | MODERNA INC | 30,000 | $7.619M | 2.8% | — | — | Put | 60770K107 |
| — | CEREVEL THERAPEUTICS HLDNG I | 225,000 | $7.295M | 2.6% | $19.56 | — | COM | 15678U128 |
| NVAX | NOVAVAX INC | 50,000 | $7.154M | 2.6% | — | — | Put | 670002401 |
| — | ARYA SCIENCES ACQUISITN CORP | 702,500 | $6.807M | 2.5% | $9.88 | — | CLASS A ORD SHS | G31658100 |
| CYTK | CYTOKINETICS INC | 145,552 | $6.634M | 2.4% | $26.44 | +46.0% | COM NEW | 23282W605 |
| ACRS | ACLARIS THERAPEUTICS INC | 400,000 | $5.816M | 2.1% | $18.76 | -19.2% | COM | 00461U105 |
| — | REPARE THERAPEUTICS INC | 271,778 | $5.732M | 2.1% | $21.09 | — | COM | 760273102 |
| — | BRIDGEBIO PHARMA INC | 7,500,000 | $5.529M | 2.0% | $0.74 | — | NOTE 2.500% 3/1 | 10806XAB8 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 65,000 | $5.508M | 2.0% | $82.16 | 0.0% | COM | 558868105 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 1,049,721 | $5.438M | 2.0% | $10.24 | -47.7% | COM | 63909J108 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 77,500 | $5.238M | 1.9% | $70.84 | -1.3% | COM | G31249108 |
| — | CURIS INC | 1,050,000 | $4.998M | 1.8% | $7.79 | — | Call | 231269200 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 419,144 | $4.72M | 1.7% | $14.78 | — | SPONSORED ADS | 152309100 |
| XENE | XENON PHARMACEUTICALS INC | 150,500 | $4.702M | 1.7% | $25.73 | +16.1% | COM | 98420N105 |
| — | BELLUS HEALTH INC NEW | 500,000 | $4.025M | 1.5% | $4.84 | — | COM NEW | 07987C204 |
| — | ARYA SCIENCES ACQU CORP IV | 400,000 | $3.972M | 1.4% | $10.47 | — | CL A | G31659108 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 100,000 | $3.864M | 1.4% | $34.15 | +27.6% | COM NEW | 15117B202 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 175,000 | $3.831M | 1.4% | $18.48 | 0.0% | COM | 87164F105 |
| — | CYMABAY THERAPEUTICS INC | 1,122,244 | $3.793M | 1.4% | $3.38 | — | COM | 23257D103 |
| RCKT | ROCKET PHARMACEUTICALS INC | 165,000 | $3.602M | 1.3% | $32.73 | -16.7% | COM | 77313F106 |
| — | CURIS INC | 650,000 | $3.094M | 1.1% | $7.79 | — | COM NEW | 231269200 |
| — | HEALTH SCIENCES ACQ CORP 2 | 300,000 | $3M | 1.1% | $12.02 | — | ORD SHS | G4411D109 |
| — | ENVIRONMENTAL IMPACT ACQU CO | 300,000 | $2.976M | 1.1% | $9.89 | — | COM CL A | 29408N106 |
| — | MIRATI THERAPEUTICS INC | 20,000 | $2.934M | 1.1% | $176.91 | — | COM | 60468T105 |
| — | MEDICUS SCIENCES ACQUISITION | 300,000 | $2.916M | 1.1% | $9.65 | — | CL A SHS | G5960S108 |
| PRCT | PROCEPT BIOROBOTICS CORP | 100,000 | $2.501M | 0.9% | $38.08 | -2.9% | COM | 74276L105 |
| — | SCIENCE 37 HOLDINGS INC | 150,000 | $1.871M | 0.7% | $12.47 | — | COM | 808644108 |
| — | CUREVAC N V | 50,000 | $1.716M | 0.6% | — | — | Call | N2451R105 |
| TVTX | TRAVERE THERAPEUTICS INC | 50,000 | $1.552M | 0.6% | $18.37 | +53.3% | COM | 89422G107 |
| — | CYCLACEL PHARMACEUTICALS INC | 400,000 | $1.548M | 0.6% | $7.22 | — | COM | 23254L603 |
| ARKG | ARK ETF TR | 25,000 | $1.531M | 0.6% | — | — | Call | 00214Q302 |
| NTLA | INTELLIA THERAPEUTICS INC | 10,000 | $1.182M | 0.4% | $102.38 | +22.4% | COM | 45826J105 |
| SEER | SEER INC | 50,000 | $1.141M | 0.4% | — | — | Call | 81578P106 |
| — | INOVIO PHARMACEUTICALS INC | 200,000 | $998K | 0.4% | — | — | Call | 45773H201 |
| — | RENOVACOR INC | 125,000 | $963K | 0.3% | $8.94 | — | COM | 75989E106 |
| — | IMMATICS N.V | 190,000 | $834K | 0.3% | $2.88 | — | *W EXP 07/01/2020 | N44445117 |
| HYPR | HYPERFINE INC | 76,162 | $552K | 0.2% | $9.78 | 0.0% | COM CL A | 44916K106 |
| RFL | RAFAEL HLDGS INC | 101,200 | $516K | 0.2% | — | — | Put | 75062E106 |
| LIANY | LIANBIO SPONSORED | 72,406 | $446K | 0.2% | $6.16 | — | ADS | 53000N108 |
| ALDX | ALDEYRA THERAPEUTICS INC | 100,759 | $403K | 0.1% | $10.02 | -23.9% | COM | 01438T106 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 20,000 | $382K | 0.1% | $27.49 | -19.9% | COM | 462260100 |
| — | RENOVACOR INC | 75,000 | $43,000 | 0.0% | $0.80 | — | *W EXP 99/99/999 | 75989E114 |
| — | MEDICUS SCIENCES ACQUISITION | 33,333 | $24,000 | 0.0% | $1.02 | — | *W EXP 02/12/2026 | G5960S124 |